ArticlePakistan journal of medical sciences2026
Sepiolite and Zirconia Nanoparticles Doped with Erythrosine: Adhesive Bond Strength and Antimicrobial Performance in Primary Carious Dentin.
Article in Pakistan journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Antimicrobial effectiveness against Lactobacillus and micro tensile bond strength (μTBS) of etch and rinse adhesive (ERA) modified using Erythrosine (Ery), Ery-doped Zirconium oxide nanoparticles (ZrO Methodology: The present in vitro study was approved by the Institutional Review Board and Ethical Committee of Princess Nourah Binte Abdul Rahman University, IRB# 25-0063. The study duration was two months, November 20, 2025 - January 20, 2026. Primary CAD was removed. All the specimens were divided into four groups based on the application of ERA modification. Group-1 (Conventional ERA), Group-2 (Ery-modified ERA), Group-3 (Ery-doped ZrO Results: Group-4 (Ery-doped SepNPs-ERA) treated samples displayed the minimum survival of microorganisms (0.30 ± 0.04 CFU/mL) and the highest bond integrity (15.02±0.61MPa). However, Group-1 (Unmodified ERA) exhibited the highest bacterial survival count (0.65 ± 0.11 CFU/mL) and the lowest μTBS (10.95 ± 0.55 MPa). Conclusion: Ery-doped ZrO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.